What is AristaMD?
AristaMD operates at the intersection of digital health and clinical efficiency, providing a sophisticated eConsult platform that facilitates seamless communication between primary care physicians and specialists. By integrating directly into existing clinical workflows, the platform empowers providers to conduct virtual consultations, thereby reducing the necessity for traditional face-to-face referrals. This approach not only enhances patient outcomes through more timely access to expert medical advice but also significantly lowers operational costs for payers and health systems. As a key player in the telehealth sector, AristaMD is uniquely positioned to address the inefficiencies inherent in the traditional referral process, offering a scalable solution that aligns with the industry-wide shift toward high-quality, cost-effective care delivery.
How much funding has AristaMD raised?
AristaMD has raised a total of $57.4M across 7 funding rounds:
Debt
$2.1M
Debt
$1.4M
Debt
$1.4M
Series A
$11M
Debt
$1M
Series B
$24M
Series C
$16.5M
Debt (2014): $2.1M with participation from Avalon Ventures, LLC
Debt (2015): $1.4M led by Undisclosed
Debt (2016): $1.4M supported by GoFormz Inc.
Series A (2016): $11M featuring Correlation Ventures and Avalon Ventures
Debt (2017): $1M, investors not publicly disclosed
Series B (2020): $24M with participation from Ascension Ventures Ltd, Stanford Health Care, MemorialCare, Avalon Ventures, CU Healthcare Innovation Fund, .406 Capital, and Cigna Ventures
Series C (2023): $16.5M, investors not publicly disclosed
Key Investors in AristaMD
Avalon Ventures
Avalon Ventures is a venture capital firm with over 30 years of experience focusing on seed and early-stage companies, particularly in the life sciences and information technology sectors.
MemorialCare
Founded in 1907, MemorialCare is a prominent hospital system operating primary hospitals and multiple outpatient facilities, providing a strategic clinical perspective to its investments.
Correlation Ventures
Correlation Ventures is a data-driven investment firm that utilizes advanced analytics to support high-growth companies in transforming their respective industries.
What's next for AristaMD?
With the recent influx of capital, AristaMD is poised to accelerate its growth strategy, focusing on the deeper integration of its eConsult platform across diverse healthcare networks. The company is expected to prioritize the expansion of its panel of board-certified experts and enhance its data-driven referral analytics to further improve clinical decision-making. As the healthcare industry continues to prioritize value-based care, AristaMD's ability to demonstrate measurable cost savings and improved patient satisfaction will be instrumental in securing additional market share. Future strategic initiatives will likely involve scaling its technological infrastructure to support higher volumes of virtual consults, ensuring that the firm remains at the forefront of the digital health transformation.
See full AristaMD company page
